G-CSF for Imatinib-induced neutropenia

Leukemia (2003) 17, 805-807. doi:10.1038/sj.leu.2402869

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia 2003-04, Vol.17 (4), p.805-807
Hauptverfasser:	Heim, D, Ebnöther, M, Meyer-Monard, S, Tsakiris, D, Linn, M, Tichelli, A, Gratwohl, A
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antineoplastic Agents - adverse effects Antineoplastic Agents - therapeutic use Benzamides Blast Crisis - blood Blast Crisis - drug therapy Clinical Trials, Phase II as Topic Enzyme Inhibitors - adverse effects Enzyme Inhibitors - therapeutic use Female Follow-Up Studies Granulocyte colony-stimulating factor Granulocyte Colony-Stimulating Factor - therapeutic use Humans Imatinib Imatinib Mesylate Leukemia, Myelogenous, Chronic, BCR-ABL Positive - blood Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy Leukemia, Myeloid, Accelerated Phase - blood Leukemia, Myeloid, Accelerated Phase - drug therapy Male Middle Aged Neutropenia Neutropenia - chemically induced Neutropenia - drug therapy Piperazines - adverse effects Piperazines - therapeutic use Pyrimidines - adverse effects Pyrimidines - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!